Archimedes Partners Acquires German Bionic to Scale AI-Powered Exoskeleton Platform
Archimedes Partners Acquires German Bionic to Scale AI-Powered Exoskeleton Platform
Archimedes Partners has acquired German Bionic, a global technology leader in AI-powered exoskeletons, marking the beginning of the company’s next growth phase. The strategic acquisition strengthens German Bionic’s financial foundation and supports the international scaling of its Physical AI platform. Since 2018, the company has developed intelligent wearable robotics for logistics, industry, and healthcare, helping reduce physical strain and enhance resilience in critical infrastructure sectors. With its flagship model Exia—recognized as one of the most powerful active back-support exoskeletons on the market—German Bionic continues to expand the role of human-centered robotics at the intersection of AI, mobility, and AgeTech.
Archimedes Partners has acquired German Bionic, a global technology leader in AI-powered exoskeletons, marking the beginning of the company’s next growth phase. The strategic acquisition strengthens German Bionic’s financial foundation and supports the international scaling of its Physical AI platform. Since 2018, the company has developed intelligent wearable robotics for logistics, industry, and healthcare, helping reduce physical strain and enhance resilience in critical infrastructure sectors. With its flagship model Exia—recognized as one of the most powerful active back-support exoskeletons on the market—German Bionic continues to expand the role of human-centered robotics at the intersection of AI, mobility, and AgeTech.
Copy link to share
Copy link to share
Link copied to clipboard !
Copy link to share
Link copied to clipboard !
Augsburg / Baar, Switzerland – Archimedes Partners has acquired German Bionic, a global technology leader in AI-powered exoskeletons. The transaction marks the beginning of the company’s next growth phase, focused on scaling its Physical AI platform, expanding international market presence, and unlocking new application fields.
Since 2018, German Bionic has been developing intelligent wearable robotics for logistics, intralogistics, industrial operations, and healthcare. In nursing and elderly care—sectors facing acute labor shortages—as well as in logistics, the backbone of global supply chains, the company’s systems reduce physical strain while strengthening the resilience of critical infrastructure.
German Bionic’s customers include major logistics providers such as FedEx and Dachser, global enterprises including Pfizer, as well as numerous hospitals and airports worldwide.
With its latest model, Exia, the company sets new standards in Human Augmentation — robotic systems designed to support the human body during physically demanding tasks.
Exia: AI-Powered Performance
Exia was introduced in summer 2025 at The Wall Street Journal’s Future of Everything Festival in New York and received the CES 2026 Health Tech Award in Las Vegas. It is widely regarded as the most powerful active back-support exoskeleton currently available on the market.
German Bionic is a pioneer in integrating artificial intelligence into wearable robotics. Exia analyzes movement patterns in real time and dynamically adapts assistance to each individual user.
“Every person moves differently and requires tailored support. We have developed our own AI-driven operating system — unique in this form worldwide. Based on our technology platform and billions of real-world motion data points, we can unlock new application scenarios far beyond traditional industrial workflows, including mobility and AgeTech,” says Norma Steller, Co-CTO of German Bionic.
Strategic Advancement
With the acquisition by Archimedes Partners, German Bionic enters a new phase of financial stability and strategic growth.
“With the new ownership, German Bionic gains a sustainable long-term financial foundation and expanded strategic flexibility. The company’s technology demonstrates that exoskeletons represent far more than a single product — they are a platform for human-centered robotics. The conditions are now in place to systematically advance the next stages of development,” says Oliver Schartl, attorney at Müller-Heydenreich Bierbach & Kollegen, who advised on the transaction.
Physical AI: A Market of the Future
Exoskeletons represent the next generation of AI applications — often referred to as Physical AI: systems that combine robotics and artificial intelligence to operate directly in the physical world.
As human-machine systems, they merge human cognitive capability with robotic strength. A dedicated version of Exia was developed in collaboration with the nursing research department of Charité – Universitätsmedizin Berlin to address the specific demands of clinical care environments.
In healthcare, social and emotional intelligence remains with the caregiver, while the exoskeleton provides physical relief. In industrial environments, the strategic relevance of the technology is equally evident: logistics and intralogistics are core components of modern economies and critical infrastructure.
At the same time, demographic change is accelerating this dynamic. As the baby boomer generation retires, demand for AgeTech solutions—technologies that enable people to remain autonomous and mobile for longer—is rising significantly. Exoskeletons are increasingly evolving into a foundational infrastructure technology at the intersection of robotics, AI, and human performance.
“With our technological leadership and strengthened financial foundation, German Bionic is exceptionally well positioned to actively shape the next phase of robotics and AI development,” says Armin G. Schmidt, Founder of German Bionic.
About German Bionic
German Bionic is a European robotics company that develops and manufactures intelligent exoskeletons and wearable technologies. As the world’s first company to introduce a connected exoskeleton for industrial workplaces, German Bionic integrates AI-based lifting support and ergonomic posture assistance into real-world working environments. Intelligent power suits such as Exia protect worker health, measurably reduce injury risks, and improve operational processes.
The company has received numerous international awards, including the CES “Best of Innovation” Award, the Fast Company “Innovation by Design” Award, and the European Investment Bank’s “Innovation Champion” Award. German Bionic operates globally with offices in Europe, North America, and Asia.
About Archimedes Partners
Archimedes Partners is a long-term oriented investor providing entrepreneurial capital for strategic investments with sustainable growth potential. The firm focuses on companies with internationally leading products and strong positive market impact.
Augsburg / Baar, Switzerland – Archimedes Partners has acquired German Bionic, a global technology leader in AI-powered exoskeletons. The transaction marks the beginning of the company’s next growth phase, focused on scaling its Physical AI platform, expanding international market presence, and unlocking new application fields.
Since 2018, German Bionic has been developing intelligent wearable robotics for logistics, intralogistics, industrial operations, and healthcare. In nursing and elderly care—sectors facing acute labor shortages—as well as in logistics, the backbone of global supply chains, the company’s systems reduce physical strain while strengthening the resilience of critical infrastructure.
German Bionic’s customers include major logistics providers such as FedEx and Dachser, global enterprises including Pfizer, as well as numerous hospitals and airports worldwide.
With its latest model, Exia, the company sets new standards in Human Augmentation — robotic systems designed to support the human body during physically demanding tasks.
Exia: AI-Powered Performance
Exia was introduced in summer 2025 at The Wall Street Journal’s Future of Everything Festival in New York and received the CES 2026 Health Tech Award in Las Vegas. It is widely regarded as the most powerful active back-support exoskeleton currently available on the market.
German Bionic is a pioneer in integrating artificial intelligence into wearable robotics. Exia analyzes movement patterns in real time and dynamically adapts assistance to each individual user.
“Every person moves differently and requires tailored support. We have developed our own AI-driven operating system — unique in this form worldwide. Based on our technology platform and billions of real-world motion data points, we can unlock new application scenarios far beyond traditional industrial workflows, including mobility and AgeTech,” says Norma Steller, Co-CTO of German Bionic.
Strategic Advancement
With the acquisition by Archimedes Partners, German Bionic enters a new phase of financial stability and strategic growth.
“With the new ownership, German Bionic gains a sustainable long-term financial foundation and expanded strategic flexibility. The company’s technology demonstrates that exoskeletons represent far more than a single product — they are a platform for human-centered robotics. The conditions are now in place to systematically advance the next stages of development,” says Oliver Schartl, attorney at Müller-Heydenreich Bierbach & Kollegen, who advised on the transaction.
Physical AI: A Market of the Future
Exoskeletons represent the next generation of AI applications — often referred to as Physical AI: systems that combine robotics and artificial intelligence to operate directly in the physical world.
As human-machine systems, they merge human cognitive capability with robotic strength. A dedicated version of Exia was developed in collaboration with the nursing research department of Charité – Universitätsmedizin Berlin to address the specific demands of clinical care environments.
In healthcare, social and emotional intelligence remains with the caregiver, while the exoskeleton provides physical relief. In industrial environments, the strategic relevance of the technology is equally evident: logistics and intralogistics are core components of modern economies and critical infrastructure.
At the same time, demographic change is accelerating this dynamic. As the baby boomer generation retires, demand for AgeTech solutions—technologies that enable people to remain autonomous and mobile for longer—is rising significantly. Exoskeletons are increasingly evolving into a foundational infrastructure technology at the intersection of robotics, AI, and human performance.
“With our technological leadership and strengthened financial foundation, German Bionic is exceptionally well positioned to actively shape the next phase of robotics and AI development,” says Armin G. Schmidt, Founder of German Bionic.
About German Bionic
German Bionic is a European robotics company that develops and manufactures intelligent exoskeletons and wearable technologies. As the world’s first company to introduce a connected exoskeleton for industrial workplaces, German Bionic integrates AI-based lifting support and ergonomic posture assistance into real-world working environments. Intelligent power suits such as Exia protect worker health, measurably reduce injury risks, and improve operational processes.
The company has received numerous international awards, including the CES “Best of Innovation” Award, the Fast Company “Innovation by Design” Award, and the European Investment Bank’s “Innovation Champion” Award. German Bionic operates globally with offices in Europe, North America, and Asia.
About Archimedes Partners
Archimedes Partners is a long-term oriented investor providing entrepreneurial capital for strategic investments with sustainable growth potential. The firm focuses on companies with internationally leading products and strong positive market impact.
German Bionic Logo